Avantax Advisory Services, Inc. Intra Cellular Therapies, Inc. Transaction History
Avantax Advisory Services, Inc.
- $13.8 Billion
- Q2 2024
A detailed history of Avantax Advisory Services, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 4,424 shares of ITCI stock, worth $378,119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,424Holding current value
$378,119% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
398Shares Held
87.5MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$821 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$540 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$318 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$294 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$256 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.07B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...